Price movement over the last 24 hours
AFLAC Incorporated vs ARK Space & Defense Innovation ETF — how do they compare? AFLAC Incorporated trades at $121.31 (market cap $61.84B), while ARK Space & Defense Innovation ETF trades at $32.19. The key difference: AFLAC Incorporated pays a 2.01% dividend while ARK Space & Defense Innovation ETF pays none, and AFLAC Incorporated is trading nearer its 52-week high, ARK Space & Defense Innovation ETF nearer its low. Which is the better fit depends on your goals.
| AFL | ARKX | |
|---|---|---|
Market Cap | $61.84B | — |
Sector | Financials | Sector/Thematic |
52-Week High | $121.49 | $37.74 |
52-Week Low | $98.09 | $24.15 |
Enterprise Value | $70.50B | — |
Dividend Yield | 2.01% | — |
Signals from Pluang's Aura AI — not financial advice
Aflac (AFL) trades at $121.49, up 0.5% with a bullish technical signal supported by moving averages. The stock shows strong fundamentals with a 25.32% net income margin and 16.47% ROE, though recent Q1 2026 earnings missed expectations. Analyst consensus is mixed with 28% buy ratings and a $113.57 price target below current levels. Recent developments include strong dividend performance and upcoming Q2 2026 results announcement on August 6, 2026.
The outlook remains cautiously optimistic with solid profitability and dividend stability, but faces headwinds from recent earnings misses and premium valuation pressure. Key opportunities include continued growth in Japan and U.S. markets, while risks involve medical cost inflation and uneven revenue trends. The stock's current premium to analyst targets suggests limited near-term upside potential.
ARK Space Exploration & Innovation ETF (ARKX) trades at $34.07, up 0.59% with a bullish technical signal from moving averages. The fund provides diversified exposure to the growing space economy, including SpaceX (8.31% weighting) and Rocket Lab (6.27%), benefiting from strong sector momentum and $500+ billion commercial space backlog. Recent SpaceX IPO has driven significant investor interest in space-themed ETFs.
ARKX offers growth potential through disruptive space technology exposure but carries higher volatility than traditional aerospace ETFs. Key risks include SpaceX valuation concerns, sector concentration, and regulatory uncertainties. The fund's active management approach provides strategic positioning in emerging space markets but comes with elevated expense ratios compared to passive alternatives.
Trailing returns across standard periods
Aflac Inc offers supplemental health insurance and life insurance in the two largest insurance markets in the world, the U.S. and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accidents, disability, and long-term-care insurance. It markets its products through independent distributors, selling most of its policies directly to consumers at their places of work.
Read more on AFL →ARKX is an actively managed ETF that invests in companies leading space exploration and defense innovation. It focuses on orbital and sub-orbital aerospace, reusable rockets, and enabling technologies like AI, robotics, and satellite systems.
Read more on ARKX →